ERBB2 and cancer: TAS-117 inhibits the proliferation of various human cancer cell lines in vitro, including breast, endometrial, lung and ovarian cancer cells with Akt2 or human epidermal growth factor type 2 (HER2) gene amplification, PIK3C mutations or PTEN loss [140].